secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2026-06-05T20:05:18+00:00
Accession:  0001193125-26-259532
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology stockholders elect three Class II directors; ratify EY as auditor
--------------------------------------------------------------------------------

- Hans E. Bishop elected with 117,452,573 For vs 57,148,432 Withheld; 30,606,441 broker non-votes.
- Robert Nelsen elected with 160,384,193 For vs 14,216,812 Withheld; 30,606,441 broker non-votes.
- Alise S. Reicin, M.D. elected with 149,865,546 For vs 24,735,459 Withheld; 30,606,441 broker non-votes.
- Ratification of Ernst & Young LLP as independent auditor for FY2026: 203,932,500 For, 831,419 Against, 443,527 Abstain.
- All director terms expire at 2029 annual meeting; no changes to board composition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526259532/0001193125-26-259532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526259532/sana-20260604.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-259532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer